Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04362 |
| Species: | Mus musculus |
| Position : | chr4:44520195-44520234 |
| Year: | 2009 |
| Title: | Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 19345119 |
| Tissue: | blood / hematopoietic system |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Lymphopoiesis B Cell |
| Cell Type: | B cell |
| Cell Ontology ID: | CL:0000236 |
| Experiment Type: | Enhancer activity assay; TF-binding/chromatin assay; In vivo functional validation |
| Low Throughput Method: | ChIP-qPCR/ChIP; EMSA/gel-shift assay; Transgenic/LacZ assay |
| Target gene : | Pax5 |
| TF name : | Irf4 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Irf4 | Calcineurin-regulated NFAT-dependent transcription in lymphocytes | pid | 50 |
| Irf4 | IL4-mediated signaling events | pid | 66 |
| Irf4 | Interferon alpha/beta signaling | reactome | 67 |
| Irf4 | Interferon gamma signaling | reactome | 88 |
| Irf4 | Hs_B_Cell_Receptor_Signaling_Pathway_WP23_89900 | wikipathways | 71 |